IHC scores for FOXO1 and PAX3 are summarized in Table 1, and data revealed that FOXO1 and PAX3 expression levels were significantly higher in EOC tissues than in borderline tumors (both p < 0.001), benign tumors (both p < 0.001), and nonadjacent normal epithelial tissues (both p < 0.001; Fig. 1b). Here, PAX3 is linked to benign neoplasm.